proposed TIGIT expression as a predictive rather than prognostic biomarker for reactive tumor-infiltrating immune cells in soft sarcoma tissue in an elegant investigation on IL-15 and TIGIT blockade therapy to reactive tumor-infiltrating immune cells (164). Here, TIGIT is linked to sarcoma.